Bogdan‐Tiberius Preca

763 total citations
7 papers, 495 citations indexed

About

Bogdan‐Tiberius Preca is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bogdan‐Tiberius Preca has authored 7 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Bogdan‐Tiberius Preca's work include Cancer Cells and Metastasis (3 papers), Peptidase Inhibition and Analysis (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). Bogdan‐Tiberius Preca is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Peptidase Inhibition and Analysis (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). Bogdan‐Tiberius Preca collaborates with scholars based in Germany, Switzerland and Austria. Bogdan‐Tiberius Preca's co-authors include Thomas Brabletz, Simone Brabletz, Marc P. Stemmler, Ulrich T. Hopt, Ulrich F. Wellner, Jochen Maurer, Tilman Brummer, Peter Bronsert, Vignesh Sundararajan and Karolina Bajdak-Rusinek and has published in prestigious journals such as International Journal of Cancer, Oncotarget and EMBO Molecular Medicine.

In The Last Decade

Bogdan‐Tiberius Preca

7 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bogdan‐Tiberius Preca Germany 7 358 269 152 69 41 7 495
Sara Koenig McLaughlin United States 4 337 0.9× 141 0.5× 133 0.9× 62 0.9× 87 2.1× 4 491
Hezhe Lu China 7 530 1.5× 189 0.7× 250 1.6× 48 0.7× 50 1.2× 15 650
Weimin Hu United States 8 305 0.9× 188 0.7× 79 0.5× 88 1.3× 25 0.6× 10 431
Camilla Avivi Israel 5 242 0.7× 218 0.8× 138 0.9× 32 0.5× 41 1.0× 6 409
Zhefu Ma United States 12 551 1.5× 251 0.9× 145 1.0× 31 0.4× 45 1.1× 12 634
Makoto Nagahara Japan 10 365 1.0× 136 0.5× 266 1.8× 83 1.2× 63 1.5× 17 539
Shuyun Yang China 15 383 1.1× 139 0.5× 136 0.9× 69 1.0× 47 1.1× 18 490
Hanne Puntervoll Norway 7 321 0.9× 228 0.8× 78 0.5× 49 0.7× 50 1.2× 11 431
Qianze Dong China 13 320 0.9× 83 0.3× 122 0.8× 63 0.9× 44 1.1× 17 418
Qing-Shan Wang China 9 344 1.0× 174 0.6× 136 0.9× 23 0.3× 51 1.2× 10 462

Countries citing papers authored by Bogdan‐Tiberius Preca

Since Specialization
Citations

This map shows the geographic impact of Bogdan‐Tiberius Preca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bogdan‐Tiberius Preca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bogdan‐Tiberius Preca more than expected).

Fields of papers citing papers by Bogdan‐Tiberius Preca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bogdan‐Tiberius Preca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bogdan‐Tiberius Preca. The network helps show where Bogdan‐Tiberius Preca may publish in the future.

Co-authorship network of co-authors of Bogdan‐Tiberius Preca

This figure shows the co-authorship network connecting the top 25 collaborators of Bogdan‐Tiberius Preca. A scholar is included among the top collaborators of Bogdan‐Tiberius Preca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bogdan‐Tiberius Preca. Bogdan‐Tiberius Preca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Coissieux, Marie‐May, Vincent Romanet, Atul Sethi, et al.. (2023). PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer. Journal of Mammary Gland Biology and Neoplasia. 28(1). 13–13. 7 indexed citations
2.
Preca, Bogdan‐Tiberius, Alexander Nyström, Catharina Conrad, et al.. (2018). ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Molecular Oncology. 13(2). 456–479. 33 indexed citations
3.
Preca, Bogdan‐Tiberius, Karolina Bajdak-Rusinek, Vignesh Sundararajan, et al.. (2017). A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer. Oncotarget. 8(7). 11530–11543. 59 indexed citations
4.
Preca, Bogdan‐Tiberius, Corinne Vannier, David J. Castro, et al.. (2016). ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget. 7(50). 83278–83293. 17 indexed citations
5.
Brabletz, Simone, Bogdan‐Tiberius Preca, Manuel Ruh, et al.. (2015). ZEB 1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Molecular Medicine. 7(6). 831–847. 188 indexed citations
6.
Preca, Bogdan‐Tiberius, et al.. (2015). The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors. Oncotarget. 6(16). 14399–14412. 46 indexed citations
7.
Preca, Bogdan‐Tiberius, Karolina Bajdak-Rusinek, Vignesh Sundararajan, et al.. (2015). A self‐enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. International Journal of Cancer. 137(11). 2566–2577. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026